Your browser doesn't support javascript.
loading
Second cancers in MPN: Survival analysis from an international study.
Marchetti, Monia; Ghirardi, Arianna; Masciulli, Arianna; Carobbio, Alessandra; Palandri, Francesca; Vianelli, Nicola; Rossi, Elena; Betti, Silvia; Di Veroli, Ambra; Iurlo, Alessandra; Cattaneo, Daniele; Finazzi, Guido; Bonifacio, Massimiliano; Scaffidi, Luigi; Patriarca, Andrea; Rumi, Elisa; Casetti, Ilaria Carola; Stephenson, Clemency; Guglielmelli, Paola; Elli, Elena Maria; Palova, Miroslava; Rapezzi, Davide; Erez, Daniel; Gomez, Montse; Wille, Kai; Perez-Encinas, Manuel; Lunghi, Francesca; Angona, Anna; Fox, Maria Laura; Beggiato, Eloise; Benevolo, Giulia; Carli, Giuseppe; Cacciola, Rossella; McMullin, Mary Frances; Tieghi, Alessia; Recasens, Valle; Isfort, Susanne; Pane, Fabrizio; De Stefano, Valerio; Griesshammer, Martin; Alvarez-Larran, Alberto; Vannucchi, Alessandro Maria; Rambaldi, Alessandro; Barbui, Tiziano.
Afiliação
  • Marchetti M; Oncology Unit, Cardinal Massaia Hospital, Asti, Italy.
  • Ghirardi A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Masciulli A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Carobbio A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Palandri F; Institute of Hematology "L. and A. Seràgnoli", S. Orsola-Malpighi Hospital, Bologna, Italy.
  • Vianelli N; Institute of Hematology "L. and A. Seràgnoli", S. Orsola-Malpighi Hospital, Bologna, Italy.
  • Rossi E; Institute of Hematology, Catholic University, Rome, Italy.
  • Betti S; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Di Veroli A; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Iurlo A; Rete Laziale MPN, Rome, Italy.
  • Cattaneo D; Division of Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, and University of Milan, Milan, Italy.
  • Finazzi G; Division of Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, and University of Milan, Milan, Italy.
  • Bonifacio M; Division of Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Scaffidi L; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Patriarca A; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Rumi E; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Casetti IC; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo Pavia, Pavia, Italy.
  • Stephenson C; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Guglielmelli P; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Elli EM; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Palova M; CRIMM-Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy.
  • Rapezzi D; Department Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
  • Erez D; Division of Hematology, Ospedale San Gerardo, ASST, Monza, Italy.
  • Gomez M; Department of Hemato-oncology, University Hospital Olomouc, Olomouc, Czech Republic.
  • Wille K; S.C. Ematologia, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy.
  • Perez-Encinas M; Hematology Institute and Blood Bank, Meir Medical Center, Kfar Saba, Israel.
  • Lunghi F; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Angona A; Department of Hematology, Hospital Clínico Universitario, Valencia, Spain.
  • Fox ML; University Clinic for Hematology and Oncology Minden, University of Bochum, Minden, Germany.
  • Beggiato E; Deparment of Hematology, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Benevolo G; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Carli G; Department of Hematology, Hospital del Mar, Barcelona, Spain.
  • Cacciola R; Department of Hematology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • McMullin MF; Unit of Hematology, Department of Oncology, University of Torino, Torino, Italy.
  • Tieghi A; Division of Hematology, Città della Salute e della Scienza Hospital, Torino, Italy.
  • Recasens V; Division of Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Isfort S; Haemostasis Unit, Department of Clinical and Experimental Medicine, University of Catania, "Policlinico-Vittorio Emanuele" Hospital, Catania, Italy.
  • Pane F; Centre for Medical Education, Queen's University Belfast, Belfast, UK.
  • De Stefano V; Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Griesshammer M; Department of Hematology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Alvarez-Larran A; Center for Translational & Clinical Research Aachen (CTC-A), University Hospital RWTH Aachen, Aachen, Germany.
  • Vannucchi AM; Department of Medicine and Surgery, Hematology and Hematopoietic Stem Cell Transplant Center, University of Naples Federico II, Naples, Italy.
  • Rambaldi A; Institute of Hematology, Catholic University, Rome, Italy.
  • Barbui T; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Am J Hematol ; 95(3): 295-301, 2020 03.
Article em En | MEDLINE | ID: mdl-31816122
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias Hematológicas / Transtornos Mieloproliferativos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias Hematológicas / Transtornos Mieloproliferativos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália